Biodistribution study of Pb progeny released from intravenously applied Ra labelled TiO nanoparticles in a mouse model.

Background: Targeted alpha therapy is one of the most powerful therapeutical modalities available in nuclear medicine. It's therapeutic potency is based on the nuclides that emit one or several alpha particles providing strong and highly localized therapeutic effects. However, some of these radionuclides, like e.